Introduction to the HESI DART Drugs in Semen Consortium.

Chen, Connie L; Beyer, Bruce K; Breslin, William J; DeLise, Anthony M; Hui, Julia Y; Moffat, Graeme J; Thompson, Kary E

Chen, Connie L; Beyer, Bruce K; Breslin, William J; DeLise, Anthony M; Hui, Julia Y; Moffat, Graeme J; Thompson, Kary E.

Afiliación

Chen CL; ILSI - Health and Environmental Sciences Institute, Washington, DC, United States. Electronic address: cchen@hesiglobal.org.
Beyer BK; Sanofi U.S., Inc., Bridgewater, NJ, United States.
Breslin WJ; Lilly Research Laboratories, Indianapolis, IN, United States.
DeLise AM; Novartis Pharmaceutical Corporation, East Hanover, NJ, United States.
Hui JY; Celgene Corporation, Summit, NJ, United States.
Moffat GJ; Amgen, Inc., Seattle, WA, United States.
Thompson KE; Bristol-Myers Squibb, New Brunswick, NJ, United States.

Reprod Toxicol ; 48: 113-4, 2014 Sep.

Article en En | MEDLINE | ID: mdl-24803405

Asunto(s)

Exposición Materna; Preparaciones Farmacéuticas/metabolismo; Semen/metabolismo; Animales; Femenino; Humanos; Masculino; Embarazo; Pruebas de Toxicidad/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Semen / Preparaciones Farmacéuticas / Exposición Materna Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: Reprod Toxicol Asunto de la revista: EMBRIOLOGIA / MEDICINA REPRODUTIVA / TOXICOLOGIA Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google